Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth
Small-cap, Buy-rated Stocks With Positive Estimate Revision Factors - BofA
Oppenheimer Maintains Keros Therapeutics(KROS.US) With Buy Rating, Raises Target Price to $102
Express News | Keros Therapeutics Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $102
Keros Therapeutics Initiated at Outperform by Oppenheimer
Express News | Oppenheimer Initiates Coverage On Keros Therapeutics With Outperform Rating, Announces Price Target of $102
Truist Financial Initiates Keros Therapeutics(KROS.US) With Buy Rating
Truist Securities Maintains Buy on Keros Therapeutics, Maintains $100 Price Target
A Quick Look at Today's Ratings for Keros Therapeutics(KROS.US), With a Forecast Between $80 to $100
Keros Therapeutics Names Chief Executive Officer Jasbir Seehra as Board Chair
Express News | Keros Therapeutics:Filed Prospectus Supplement to Co's Shelf Registration Statement for Issuance & Sale of up to $350 Mln Shares of Common Stock
Express News | Keros Therapeutics Appointed Jasbir S. Seehra Chief Executive Officer, Chair Of The Board, Effective July 1, 2024; Christopher Rovaldi Promoted To President, Effective July 1, 2024
Keros Therapeutics Rovaldi Will Also Continue Serving as Oper Chief >KROS
Express News | Keros Therapeutics Inc: Christopher Rovaldi Has Been Promoted to President, Effective July 1, 2024
Express News | Keros Therapeutics Inc - Appointed Jasbir S. Seehra, Ph.d., Chief Executive Officer, as Chair of Board, Effective July 1, 2024.
Keros Therapeutics Seehra Will Succeed Current Chair Carl L. Gordo Effective July 1
Express News | Keros Therapeutics Announces Leadership Updates
Keros Therapeutics Presented Additional Data From Its Two Ongoing Phase 2 Trials Of Elritercept (KER-050), For Very Low-, Low-, Or Intermediate-Risk Myelodysplastic Syndromes And Myelofibrosis
Keros Therapeutics Presents Clinical Data From Its Elritercept (KER-050) Program at the 29th Annual Hybrid Congress of the European Hematology Association
Catalyst Watch: HP Enterprise Event, Walmart+ Week, Pure Storage Buzz, and Triple-witching Volatility